News Releases

July 30, 2019 at 4:05 PM EDT

Summary Toggle CryoLife Reports Second Quarter 2019 Financial Results

ATLANTA , July 30, 2019 /PRNewswire/ -- Second Quarter and Recent Business Highlights: Total revenues were $71.1 million in the second quarter of 2019, reflecting year over year growth of 4% and a 7% increase on a non-GAAP constant currency basis, both compared to the second quarter of 2018
July 25, 2019 at 8:34 AM EDT

Summary Toggle CryoLife to Present at Canaccord Genuity 39th Annual Growth Conference

ATLANTA , July 25, 2019 CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Canaccord Genuity 39 th Annual Growth Conference on Thursday, August 8, 2019 at the InterContinental Boston Hotel .
July 17, 2019 at 8:34 AM EDT

Summary Toggle CryoLife Announces Release Date and Teleconference Call Details for 2019 Second Quarter Financial Results

ATLANTA , July 17, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 second quarter financial results will be released on Tuesday, July 30, 2019 after the market closes. On that day, the Company will
April 30, 2019 at 4:05 PM EDT

Summary Toggle CryoLife Reports First Quarter 2019 Financial Results

ATLANTA , April 30, 2019 /PRNewswire/ -- First Quarter and Recent Business Highlights: Total revenues were $67.5 million in the first quarter of 2019, reflecting year over year growth of 9% and an 11% increase on a non-GAAP constant currency basis, both compared to the first quarter of 2018 On-X ®
April 17, 2019 at 5:05 PM EDT

Summary Toggle CryoLife Announces Release Date and Teleconference Call Details for 2019 First Quarter Financial Results

ATLANTA , April 17, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 first quarter financial results will be released on Tuesday, April 30, 2019 after the market closes. On that day, the Company
April 3, 2019 at 8:30 AM EDT

Summary Toggle CryoLife to Present at 18th Annual Needham Healthcare Conference

ATLANTA , April 3, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 18 th Annual Needham Healthcare Conference on Wednesday, April 10, 2019 at the Westin Grand Central
March 5, 2019 at 5:00 PM EST

Summary Toggle CryoLife to Present at Cowen and Company 39th Annual Health Care Conference

ATLANTA , March 5, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Cowen and Company 39 th Annual Health Care Conference on Monday, March 11, 2019 at The Boston
February 13, 2019 at 7:30 PM EST

Summary Toggle CryoLife Reports Fourth Quarter and Full Year 2018 Financial Results

ATLANTA , Feb. 13, 2019 /PRNewswire/ -- Fourth Quarter and Recent Business Highlights: Total revenues were $67.8 million in the fourth quarter of 2018, reflecting year over year growth of 28% and an 8% increase on a non-GAAP constant currency basis compared to the fourth quarter of 2017 On-X ®
February 1, 2019 at 5:00 PM EST

Summary Toggle CryoLife Announces Release Date and Teleconference Call Details for 2018 Fourth Quarter and Year-end Financial Results

ATLANTA , Feb. 1, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2018 fourth quarter and year-end financial results will be released on Wednesday, February 13, 2019 after the market closes.
October 31, 2018 at 5:04 PM EDT

Summary Toggle CryoLife Reports Third Quarter 2018 Results

ATLANTA , Oct. 31, 2018 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY) , a leading cardiac and vascular surgery company focused on aortic disease, announced today its financial results for the third quarter ended September 30, 2018 . Third Quarter and Recent Business Highlights: Total revenues